ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...

Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option. Neil Minkoff, MD: As we move into different types of therapy, laser ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma can be a difficult management problem in a subset of patients, even for the most experienced glaucoma ...

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

ViaLase, a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40 million in additional finance. Based in Alisa Viejo, ...

Please provide your email address to receive an email when new articles are posted on . Frailty and older age are associated with significantly lower odds of undergoing surgery or laser treatment for ...

LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced that the American Medical Association (AMA) approved two new Category III Current Procedural Terminology (CPT®) codes to report ...